287 related articles for article (PubMed ID: 30862315)
1. Early surgical intervention for patients with possible clinically silent somatotroph adenoma: a case series.
Kawaguchi T; Ogawa Y; Tominaga T
J Med Case Rep; 2019 Mar; 13(1):85. PubMed ID: 30862315
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
6. Mitral valve repair in a patient with acromegaly.
Omoto T; Tedoriya T; Oi M; Nagano N; Miyauchi T; Ishikawa N
Ann Thorac Cardiovasc Surg; 2012; 18(2):148-50. PubMed ID: 22001216
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
8. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
[TBL] [Abstract][Full Text] [Related]
9. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
[TBL] [Abstract][Full Text] [Related]
10. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
[TBL] [Abstract][Full Text] [Related]
11. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
Hong JF; Ding XH; Wang SS
Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
[TBL] [Abstract][Full Text] [Related]
13. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
[TBL] [Abstract][Full Text] [Related]
14. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
Gradiser M; Matovinovic M; Vrkljan M
Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly resolution after traumatic brain injury: a case report.
Cob A
J Med Case Rep; 2014 Sep; 8():290. PubMed ID: 25182385
[TBL] [Abstract][Full Text] [Related]
16. Clinically silent somatotroph adenomas are common.
Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
[TBL] [Abstract][Full Text] [Related]
18. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly.
Sarkar S; Rajaratnam S; Chacko G; Chacko AG
Clin Neurol Neurosurg; 2014 Nov; 126():190-5. PubMed ID: 25278017
[TBL] [Abstract][Full Text] [Related]
19. Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
Martins AF; Santos M; Rosário F
BMC Endocr Disord; 2023 Mar; 23(1):68. PubMed ID: 36973824
[TBL] [Abstract][Full Text] [Related]
20. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]